Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide welcome guidance. Read the article in full on BioTalk here.
| less than a minute read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Get in touch
Get in touch
Get in touch
Get in touch
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-05-29-13-19-21-758-6a19925962349c94eb852556.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-02-19-12-04-25-086-6996fc49ed31acc93b14048e.png)
/Passle/MediaLibrary/Images/2025-04-30-15-29-39-675-681241e33d699cce369adb32.jpeg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-04-17-13-30-18-435-69e235ea1a76544fc58084ea.png)